Pheophytin a
Based on 1 Customer Validation
Pheophytin a is a multi-target inhibitor, anticancer agent, antioxidant and antiviral agent. Pheophytin a directly binds to and inhibits HCV-NS3/4A protease (IC50=0.89 μM) to block viral replication. Pheophytin a also scavenges free radicals, reduces ferric ions, and exhibits cytotoxic activity against breast cancer cells. Pheophytin a effectively inhibits LPS-induced production of nitric oxide, prostaglandin E2, NOS2 and COX-2, as well as various pro-inflammatory cytokines, by downregulating the transcription levels of inflammatory mediators and blocking the ERK1/2 and STAT-1 pathways. In a low nerve growth factor environment, Pheophytin a also enhances ERK1/2 phosphorylation and synergistically promotes neurite outgrowth through MAPK pathway. Pheophytin a can be used to investigate the pathogenic mechanisms of diseases including chronic hepatitis C, sepsis, breast cancer and Alzheimer's disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 80.0%
- CAS No.: 603-17-8
- Formule: C55H74N4O5
- Masse moléculaire:871.20
-
Stockage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
ERK1 |
ERK2 |
COX-2 |
STAT1 |
At concentrations of 5-25 μM with a 30-min pre-incubation followed by 24 h of LPS stimulation, Pheophytin a exhibits cytotoxicity toward LPS-stimulated RAW 264.7 murine macrophages at 25 μM, but shows no such effect at 5 μM or 10 μM[1].
Pheophytin a (1-10 μM; pre-incubated for 30 min followed by LPS stimulation for 6 h) reduces LPS-induced NOS2 protein expression in RAW 264.7 mouse macrophages in a dose-dependent manner; when cells are pre-incubated with concentrations of 1, 5, or 10 μM for 30 min, the inhibitory effect at 10 μM is significant, whereas administration after LPS stimulation shows no effect[1].
Pheophytin a (1-10 μM; pre-incubated for 30 min, followed by LPS stimulation for 3 h) dose-dependently inhibits LPS-induced NOS2 mRNA expression in RAW 264.7 mouse macrophages when pre-incubated at concentrations of 1, 5 or 10 μM for 30 min, and exhibits significant inhibitory effects at all tested concentrations[1].
Pheophytin a (10 μM; pre-incubated for 30 min, 10-30 min after LPS stimulation) enhances LPS-induced ERK1/2 phosphorylation in RAW 264.7 mouse macrophages when cells are pre-incubated with 10 μM Pheophytin a for 30 min and proteins are harvested at 10, 15 or 30 min after LPS stimulation; its inhibitory effect on LPS-induced NO production is partially reversed by the ERK1/2 inhibitor U0126 (HY-12031A); Pheophytin a has no effect on LPS-induced phosphorylation of JNK, p38 or Akt[1].
The IC50 values of Pheophytin a microparticles for scavenging superoxide anion radicals and nitric oxide radicals are 200.5 μg/mL and 132.7 μg/mL, respectively; the IC50 value for cytotoxicity against MCF-7 human breast cancer cells is 35.9 μg/mL[2].
Pheophytin a (0.9-31.2 μg/mL; 48 h) dose-dependently potentiates nerve growth factor-induced neurite outgrowth in PC12 cells; the effect at 3.9 μg/mL is comparable to that of high-concentration nerve growth factor, which enhances the phosphorylation level of ERK1/2 without affecting the total ERK level or the phosphorylation levels of p38 and JNK[3].
Pheophytin a (100 nM-10 μM; 60 min) inhibits FmLP-induced chemotaxis of human polymorphonuclear leukocytes in a dose-dependent manner[4].
Pheophytin a (0.1-6 μM; 48-96 h) inhibits the expression of HCV proteins and RNA in HCV subgenomic replicon cells, with an IC50 of 4.97 μM, and exhibits synergistic anti-HCV activity with IFNa-2a[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:LPS-stimulated RAW 264.7 murine macrophages
-
Concentration:10 μM
-
Incubation Time:30 min pre-incubation; 10, 15, 30 min after LPS stimulation (protein harvest)
-
Result:Significantly increased LPS-induced ERK1/2 phosphorylation. Showed no effect on LPS-induced JNK, p38, or Akt phosphorylation. Had its suppressive effect on LPS-induced NO production partially reversed by the ERK1/2 inhibitor U0126.
-
Cell Line:PC12 rat phaeochromocytoma cells
-
Concentration:3.9 μg/ml (in presence of 10 ng/ml NGF)
-
Incubation Time:5 min (in presence of 10 ng/ml NGF)
-
Result:Did not increase total ERK protein levels. Significantly enhanced the phosphorylation of ERK1/2 in PC12 cells treated with 10 ng/ml NGF, with activation levels similar to those induced by 50 ng/ml NGF alone. Did not stimulate phosphorylation of p38 or c-Jun N-terminal kinase (JNK) in PC12 cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (8 weeks old)[4]
-
Dosage:80 nmol/20 μl; 800 nmol/20 μl
-
Administration:topical; single application
-
Result:Reduced TPA-induced ear edema to a mean ear disk weight of 12.2 ± 1.4 mg (P < 0.05 vs TPA alone).\nReduced TPA-induced ear edema to a mean ear disk weight of 8.6 ± 1.1 mg (P < 0.005 vs TPA alone).
Chemical Information
-
CAS No. 603-17-8
-
Appearance Solid
-
Masse moléculaire 871.20
-
Formule C55H74N4O5
-
Color Brown to black
-
SMILES
COC([C@@H]1/C2=C([C@H]([C@@H]3C)CCC(OC/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=O)/N=C3/C=C(C(C)=C/4C=C)\NC4=C/C5=N/C(C(CC)=C5C)=C\C6=C(C)C(C1=O)=C2N6)=O
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Pureté et documentation
-
Fiche technique (279 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Lin CY, et al. Pheophytin a inhibits inflammation via suppression of LPS-induced nitric oxide synthase-2, prostaglandin E2, and interleukin-1β of macrophages. Int J Mol Sci. 2014;15(12):22819-22834. Published 2014 Dec 9. [Content Brief]
[2]. Mohammed HA, et al. Formulation of Ethyl Cellulose Microparticles Incorporated Pheophytin A Isolated from Suaeda vermiculata for Antioxidant and Cytotoxic Activities. Molecules. 2019 Apr 17;24(8):1501. [Content Brief]
[3]. Ina A, et al. Pheophytin a, a low molecular weight compound found in the marine brown alga Sargassum fulvellum, promotes the differentiation of PC12 cells. Int J Dev Neurosci. 2007;25(1):63-68. [Content Brief]
[4]. Okai Y, et al. Potent anti-inflammatory activity of pheophytin a derived from edible green alga, Enteromorpha prolifera (Sujiao-nori). Int J Immunopharmacol. 1997;19(6):355-358. [Content Brief]
[5]. Wang SY, et al. Bioactivity-guided screening identifies pheophytin a as a potent anti-hepatitis C virus compound from Lonicera hypoglauca Miq. Biochem Biophys Res Commun. 2009;385(2):230-235. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pheophytin a Related Classifications
HY-N12586 Related Classifications
Powered by Bioz